Quarterly Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept As at
2024-09-30
As at
2024-03-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,271,000,000 JPY
18,756,000,000 JPY
Merchandise and finished goods
2,332,000,000 JPY
2,111,000,000 JPY
Work in process
7,642,000,000 JPY
6,220,000,000 JPY
Raw materials and supplies
12,790,000,000 JPY
12,602,000,000 JPY
Other
2,915,000,000 JPY
2,955,000,000 JPY
Current assets
56,307,000,000 JPY
57,581,000,000 JPY
Non-current assets
Property, plant and equipment
31,754,000,000 JPY
30,040,000,000 JPY
Property, plant and equipment
Land
10,587,000,000 JPY
10,587,000,000 JPY
Construction in progress
2,912,000,000 JPY
171,000,000 JPY
Other
Other, net
4,572,000,000 JPY
5,141,000,000 JPY
Intangible assets
3,247,000,000 JPY
3,496,000,000 JPY
Intangible assets
Patent right
2,019,000,000 JPY
2,158,000,000 JPY
Other
1,228,000,000 JPY
1,338,000,000 JPY
Investments and other assets
13,312,000,000 JPY
11,107,000,000 JPY
Investments and other assets
Investment securities
12,084,000,000 JPY
9,120,000,000 JPY
Other
1,232,000,000 JPY
1,991,000,000 JPY
Allowance for doubtful accounts
-4,000,000 JPY
-4,000,000 JPY
Non-current assets
48,314,000,000 JPY
44,644,000,000 JPY
Assets
104,622,000,000 JPY
102,226,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
16,262,000,000 JPY
8,950,000,000 JPY
Income taxes payable
122,000,000 JPY
1,657,000,000 JPY
Other
3,969,000,000 JPY
5,510,000,000 JPY
Current liabilities
34,133,000,000 JPY
30,135,000,000 JPY
Non-current liabilities
Long-term borrowings
12,150,000,000 JPY
14,350,000,000 JPY
Other
261,000,000 JPY
280,000,000 JPY
Non-current liabilities
13,438,000,000 JPY
15,615,000,000 JPY
Liabilities
47,572,000,000 JPY
45,750,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
10,392,000,000 JPY
10,384,000,000 JPY
Retained earnings
36,517,000,000 JPY
37,278,000,000 JPY
Treasury shares
-2,542,000,000 JPY
-2,963,000,000 JPY
Shareholders' equity
53,429,000,000 JPY
53,761,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
2,604,000,000 JPY
741,000,000 JPY
Deferred gains or losses on hedges
7,000,000 JPY
0 JPY
Valuation and translation adjustments
3,199,000,000 JPY
1,604,000,000 JPY
Share acquisition rights
75,000,000 JPY
812,000,000 JPY
Net assets
57,049,000,000 JPY
56,475,000,000 JPY
Liabilities and net assets
104,622,000,000 JPY
102,226,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.